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Protein-tyrosine phosphatases are key regulators of protein tyrosine
phosphorylation.More thanmerely terminating the pathways initiated by
protein-tyrosine kinases, phosphatases are active participants in many
signaling pathways. Signals involving tyrosine phosphorylation are fre-
quently generated in response to cell-matrix adhesion. In addition, high
levels of protein tyrosine phosphorylation generally promote disassembly
or turnover of adhesions. In this brief review, we will discuss the role of
protein-tyrosine phosphatases in cell-matrix adhesions.
Cell adhesion and migration are two tightly coupled processes critical to
normal development and physiology. Two types of adhesion are usually dis-
tinguished: adhesion of cells to the underlying extracellularmatrix (ECM)3 and
adhesion between adjacent cells. This review will focus on the former. Adhe-
sions are more than simple physical links to the matrix or to other cells; they
are also sites where signals are initiated, allowing cells to monitor their imme-
diate environment. Prominent among the signaling pathways that emanate
from adhesion sites are those involving protein tyrosine phosphorylation. The
differential tyrosine phosphorylation of cell adhesionmolecules and their asso-
ciated proteins is onemeans of altering the assembly and stability of adhesions.
Tyrosine phosphorylation status reflects the balance between protein-tyrosine
kinases (PTKs) and protein-tyrosine phosphatases (PTPs).
PTPs were discovered several years after PTKs and have been studied less
extensively. However, the number of genes encoding PTPs rivals that of PTKs,
suggesting that the functions of PTPs may be just as complex (1). In addition,
the diversity of phenotypes in knock-outmice lacking various PTP genes dem-
onstrates that many PTPs have non-redundant functions. Several families of
PTPs have been identified, including classical PTPs, dual specificity PTPs,
myotubularins, PTEN-related PTPs, and aspartic acid-based PTPs (2). In this
review, we will focus primarily on the classical PTPs and their functions in
cell-matrix adhesion; the role of PTPs in cell-cell adhesions will be covered in
a subsequent review (3). Classical PTPs contain a highly conserved catalytic
domain with a critical cysteine sulfhydryl in the catalytic site. They show con-
siderable diversity in their other domains, allowing for variations in binding
partners, localization, and function. In humans, 38 classical PTPs have been
identified and these fall into two groups, either transmembrane receptor-type
PTPs (RPTPs) or cytoplasmic PTPs (2). RPTPs contain extracellular domains
often resembling adhesion receptors and either single or tandem catalytic
domains in the intracellular sequence. Cytoplasmic PTPs consist of a single
catalytic domain with various amino- or carboxyl-terminal protein-binding
motifs such as SH2 or FERM domains that serve targeting or regulatory roles.
PTPs and Adhesion to Extracellular Matrix
Transmembrane receptors of the integrin family are responsible for adhe-
sion to many different ECM proteins, including fibronectin, laminin, and col-
lagen (4). For cells in tissue culture, sites of strong adhesion to the ECM are
known as focal adhesions, and they serve to anchor bundles of microfilaments
(stress fibers) to the plasma membrane via integrins. Focal adhesions not only
play a structural role but also act as scaffolds for numerous signaling pathways
downstream from integrin-mediated adhesion. Prominent among these sig-
nals is tyrosine phosphorylation of proteins at the cytoplasmic face of focal
adhesions catalyzed by PTKs such as FAK and Src family kinases (SFKs) (5).
Engagement of integrins in itself is insufficient to induce the tyrosine phospho-
rylation and activation of FAK; integrin clustering at focal adhesions is
required (6). The aggregation of integrins and resulting tyrosine phosphoryla-
tion at these sites is driven by myosin dependent cytoskeletal forces. This is, in
turn, stimulated by the RhoA/Rho kinase pathway or pathways activatingmyo-
sin light chain kinase (7). During integrin-induced adhesion, in parallel with
the activation of FAK and SFKs, there is a general inhibition of PTP activity (8).
In comparison with the large amount known about the role of PTKs in focal
adhesions, much less is known about PTPs. Several studies have reported
changes in tyrosine phosphorylation within focal adhesions in response to
manipulating specific PTPs. However, the identification of PTP targets within
focal adhesions has been difficult and sometimes contradictory. The problem
arises because tyrosine phosphorylation is important not only as a conse-
quence of integrin-mediated adhesion, but it is also involved inmany upstream
signaling pathways that affect integrin clustering and focal adhesion assembly.
Consequently, it is often difficult to discern whether manipulation of a PTP is
directly affecting the phosphorylation of a protein downstream from integrins,
or whether it is affecting focal adhesion assembly or disassembly, and thereby
indirectly affecting tyrosine phosphorylation of focal adhesion components.
Strategies used for investigating the roles of specific PTPs have included over-
expression of wild-type PTPs, expression of mutant or catalytically dead PTPs
and elimination of specific PTPs, either by knock-out or siRNA strategies.
However, all of these approachesmay influence upstream signaling and can be
misleading when the readout is the tyrosine phosphorylation of focal adhesion
components. One of the best approaches to identify specific targets is to use
catalytically dead PTPs to “trap” their substrates (9).
PTPs can affect integrin-mediated adhesion and the tyrosine phosphoryla-
tion that occurs in focal adhesions by acting at least at three different levels.
They can affect signaling upstream, for example, by regulating the activities of
GEFs and GAPs for Rho proteins; they can act proximal to integrin engage-
ment, for example, by regulating Src kinase activity; or they can dephospho-
rylate downstream targets, some ofwhichmay feed back to influence upstream
signaling pathways affecting focal adhesion assembly and turnover.
Upstream Regulation of Rho Protein Activity by Protein-
tyrosine Phosphatases: PTP-PEST, Shp-2, and LMW-PTP
Important upstream regulators of cell matrix adhesions are members of the
Rho family of small GTPases (10). In humans, this family of regulatory proteins
includes 20 proteins, although most work has been focused on three ubiqui-
tously expressed members, RhoA, Rac1, and Cdc42. Like other G proteins,
these proteins are active in the GTP-bound form and are inactive whenGTP is
hydrolyzed to GDP. Activation of Rho proteins is catalyzed by guanine nucle-
otide exchange factors (GEFs), which stimulate exchange of bound GDP with
GTP from the cytoplasmic pool. Most Rho proteins have intrinsic GTPase
activity, which is further stimulated by GTPase-activating proteins (GAPs).
Many GEFs and GAPs are regulated by tyrosine phosphorylation. Conse-
quently, PTPs can profoundly influence the cycle of Rho protein activation by
regulating the state of phosphorylation of GEFs andGAPs (Fig. 1). Examples of
PTPs that have been reported to regulate Rho protein activity are given in
Table 1.
PTP-PEST is one PTP that affects adhesion and migration, in part by regu-
lating the activity of Rho proteins. Overexpression of PTP-PEST depresses
membrane ruffling at the leading edge of cells due to decreased Rac1 activity
(11). Conversely, in PTP-PEST/ cells Rac1 activity is elevated and sus-
tained in cells plated on fibronectin (63). Several pathways bywhich PTP-PEST
might regulate Rac activity are suggested from published studies. PTP-PEST
has been shown to bind and act on both p130cas and paxillin (12, 13, 64) (Table
2). Both of these proteins, when tyrosine-phosphorylated, interact with Rac
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GEFs. Tyrosine-phosphorylated p130cas and paxillin bind the adapter Crk
(14–16), which in turn recruits the Rac GEF DOCK180 (17, 18). In addition,
paxillin binds the Rac GEF PIX via the adapter protein Pkl/Git (19, 64). There-
fore, a loss of PTP-PEST may increase Rac activity by increasing the pool of
phosphorylated p130cas and paxillin, thus preserving their interactions with
and regulation of their GEF binding partners. Recent work has revealed that
trapping mutants of PTP-PEST also bind Vav2 (63), a ubiquitously expressed
GEF regulated by tyrosine phosphorylation (20). This observation raises the
possibility that PTP-PESTmay directly regulate Rac activity by controlling the
phosphorylation state of this GEF without the need for adaptor proteins such
as p130cas/paxillin.
The increased Rac1 activity found in PTP-PEST/ fibroblasts would be
predicted to increase migration, but these cells actually have reduced migra-
tion rates (21). Examination of cell morphology reveals prominent ruffling
membranes/lamellipodia (hallmarks of active Rac1), but the cells develop elon-
gated tails, indicative of problems in detaching from the substrate (63). Elon-
gated tails are often associated with low RhoA activity (22). Through interac-
tions with both a Rac GEF and p190RhoGAP, PTP-PEST may regulate the
activities of bothGTPases, thereby influencingmigration by controllingmem-
brane ruffling and tail retraction. However, an inability to disassemble focal
adhesions in the rear would also account for the phenotype of the PTP-PEST
null cells. Focal adhesion disassembly is regulated by tyrosine phosphorylation
as well and will be discussed below. These results point to the complexity of
phenotypes generated by PTP knock-outs due to the actions of PTPs on mul-
tiple targets.
Another PTP implicated in regulating Rho protein activity is Shp-2. Here,
conflicting results have been obtained, with some groups reporting that Shp-2
inhibits RhoA activity (23, 24), while other groups find that Shp-2 stimulates
RhoA activity (25, 26), and still others suggest that Shp-2 can exert both posi-
tive and negative regulatory effects on RhoA activity (27). One target for Shp-2
is p190RhoGAP, a widely expressed GAP for RhoA (28) (Table 2). The activity of
p190RhoGAP is stimulated by tyrosine phosphorylation (28, 29). By dephospho-
rylating p190RhoGAP and so suppressing its GAP activity, Shp-2 can elevate
RhoA GTP levels (i.e. activate RhoA). Paradoxically, Shp-2 is one of the PTPs
that stimulates Src activity (see below), and Src is responsible for phosphoryl-
ation and activation of p190RhoGAP (30). Consequently, Shp-2 can act on both
sides of the phosphorylation equation regulating p190RhoGAP activity. In addi-
tion, Shp-2 may be one of the PTPs that inactivates Rho GEFs that are regu-
lated by tyrosine phosphorylation (23, 24). Thus, the apparently conflicting
role of Shp-2 with regards to RhoA activity could be reconciled by the differ-
ential action of the PTP on targets that can either positively or negatively
regulate RhoA activity.
One non-classical PTP that warrants mentioning in the context of RhoA
activity is LMW-PTP. It has been reported to act downstreamof Src to regulate
the phosphorylation state of p190RhoGAP, thereby controlling Rho-mediated
cytoskeletal rearrangement (31). LMW-PTP has also been implicated in the
cross-talk between Rac1 and RhoA, in which Rac1-mediated generation of
reactive oxygen species was observed to inhibit LMW-PTP. This elevated
p190RhoGAP tyrosine phosphorylation and activity, suppressing RhoA activity
(32).
PTPs Acting Proximal to Integrins: Shp-2, PTP, and PTP1B
What is the initiating signal downstream from integrin-mediated adhesion?
Several studies have implicated SFKs in some of the earliest steps downstream
from integrins and preceding the activation of FAK (30, 33, 34). SFKs have been
shown to bind -integrin cytoplasmic domains (35, 36), which has prompted
investigation into how these kinases are regulated in response to interaction of
the integrins with their ligands. SFKs are held in an inhibitory state by two
intramolecular interactions. One interaction involves the SH3 domain binding
to the linker region between the kinase and SH2 domains. This constraint may
be removed by association of the SFK with integrin cytoplasmic domains (37).
The second intramolecular constraint to SFK activity involves binding of the
SH2 domain to the phosphorylated COOH-terminal tyrosine residue (Tyr527
in avian, Tyr529 in mammalian cells). This inhibitory phosphorylation of Src is
catalyzed by COOH-terminal Src kinase (Csk). Csk complexes with Src and
inactive integrin IIb/3 (36). A PTPmust dephosphorylate the COOH-termi-
nal tyrosine for SFK activation. In addition, for full activity, phosphorylation of
Tyr416 must occur in the activation loop within the kinase domain. Activation
by removal of the COOH-terminal phosphate raises the possibility that PTPs
may be involved in the initiation of the signaling downstream from integrin
engagement or clustering. Several PTPs are capable of activating SFKs, and in
the context of integrins, three have been studied, Shp-2, PTP, and PTP1B
(37–41).
Cells expressing a truncated form of Shp-2 (lacking the NH2-terminal SH2
domain) reveal diminished activation of Src and elevated phosphorylation of
the inhibitory site, Tyr529, in response to adhesion to ECM (41, 42). These cells
spread more slowly and display reduced tyrosine phosphorylation of FAK,
paxillin, and p130cas (40, 41). In addition, Shp-2 may indirectly regulate Src
activity by regulating the recruitment of Csk to themembrane. Csk is recruited
to themembrane via associationwith tyrosine phosphorylated PAG (phospho-
protein associated with glycosphingolipid-enriched microdomains), a trans-
membrane glycoprotein. Shp-2 dephosphorylates PAG and abolishes the Csk-
binding site, resulting in a reduction in membrane associated Csk and a
reduction of Csk-mediated Src inhibition (42). Thus Shp-2 may activate Src
both by directly acting on its COOH-terminal phosphorylation site and by
inhibitingCsk recruitment. A protein thatmay act in parallel to PAG is SHPS-1
(SIRP1). Like PAG, SHPS-1 recruits Shp-2 to themembrane and is a target for
its activity (41, 43).
TABLE 2
Binding partners and substrates for PTPs involved in regulating cell-
matrix adhesion
PTP Binding partners Substrates






PTP Src family kinases (38) Src (39, 44)
v3 integrins (47) Fyn (44)
Yes (38)
PTP1B p130cas (48) p130cas (48)
1 integrins (51) Src (37)
PTP-PEST p130cas (13) p130cas (13)
Paxillin (12) Paxillin (12)
Csk (61) PYK2/CAK (62)
Pkl (64); Vav2 (11)
FIGURE 1. PTP regulation of integrin-mediated adhesion signaling and focal adhe-
sions. Upstream, the clustering of integrins is determined by RhoA-GTP levels (activity).
PTPs can regulate the activity of Rho proteins by controlling the phosphorylation states
of GEFs and GAPs. Downstream, integrin clustering leads to SFK and FAK activation. PTPs
can both activate and inhibit SFKs by removing inhibitory or activating phosphoryla-
tions. Regulating the tyrosine phosphorylation of downstream targets such as FAK reg-
ulates the dynamics and disassembly of focal adhesions.
TABLE 1
Regulation of Rho-GTPase activity by PTPs
PTP GTP level Target Ref.
Shp-2 1RhoA-GTP p190RhoGAP 29
1RhoA-GTP Unknown 25,a 26
2RhoA-GTP Vav, Vav2 23, 24a
PTP-PEST 2Rac1-GTP Unknown GEF 11
LMW-PTP 1RhoA-GTP p190RhoGAP 32
a Implied from phenotype; GTP levels not measured.
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PTP is a receptor-type, transmembrane PTP involved in the activation of
SFKs and in integrin signaling pathways. Ectopic expression of PTP enhances
the dephosphorylation of the COOH-terminal Tyr529, strongly activating Src
and Fyn kinases (39). Cells lacking PTP spread more slowly and contain
decreased tyrosine phosphorylation of focal adhesion components (44, 45).
The decrease in tyrosine phosphorylation of FAK, especially at autophospho-
rylation site Tyr397, in PTP/ cells suggests that this phosphatase lies
between integrins and the activation of FAK (46). PTP and the integrin v3
co-immunoprecipitate from cells spreading on ECM substrates (47). This
association has been shown to be involved in the activation of SFKs following
integrin engagement, which, in turn, is involved in the reinforcement of inte-
grin-cytoskeletal forces in response to tension (47). In this study, the SFK
involved was Fyn rather than Src. No evidence for an interaction between 1
integrins and PTP was seen, but because similar downstream responses are
observed for 1 and 3 integrins, it seems likely that parallel pathways may
operate, possibly involving different PTPs and different SFKs.
In platelets, activation of Src occurs rapidly in response to integrin engage-
ment, whereas FAK activation is a relatively late event (33). The association of
Src with the 3 cytoplasmic domain involves binding via its SH3 domain,
relieving one of the inhibitory constraints on Src (37).With plateletIIb/3, the
activation involves release of associated Csk from the integrin-SFK complex
and the subsequent recruitment of PTP1B. Interestingly, the recruitment of
PTP1B requires tyrosine phosphorylation of PTP1B and is blocked by Src
inhibitors (37). This implies that some level of Src activation must precede the
recruitment of PTP1B. Shattil and colleagues (37) propose a model in which
binding of IIb/3 to fibrinogen induces micro-clustering of IIb/3, juxtapos-
ing Src molecules so that these cross-phosphorylate on Tyr416. It is suggested
that this results in initial activation sufficient to phosphorylate and recruit
PTP1B, which, by removing the COOH-terminal phosphorylation of Src,
results in full activity. In this model, many of the subsequent tyrosine phos-
phorylations, including FAK activation, are triggered downstream from these
initial events (37).
Differential PTP1B Signaling in Various Cell Types
With regard to its role in ECM adhesion, conflicting results have been
reported for PTP1B. The finding that PTP1B binds and acts on p130cas (48) led
to experiments investigating the effects of expressing wild-type or mutant
forms of PTP1B unable to bind to p130cas in cell adhesion situations. Expres-
sion of wild-type, but not mutant, PTP1B slowed fibroblast spreading and
depressed tyrosine phosphorylation of p130cas and other proteins in response
to adhesion (49). In addition, the expression of wild-type PTP1B enhanced the
assembly of focal adhesions with short thick stress fibers and decreased cell
migration. Consistent with these findings, depressing PTP1B expression in
vascular smooth muscle enhanced tyrosine phosphorylation of p130cas and
stimulated migration (50). Seemingly contradictory results, however, were
obtained in another study in which wild-type or catalytically dead PTP1Bwere
expressed in L cells (51). In these experiments, expression of the wild-type
PTP1B did not depress tyrosine phosphorylation in response to adhesion to
fibronectin, whereas expression of a catalytically dead mutant did. Expression
of the inactive mutant also suppressed Src activity and depressed cell attach-
ment to a fibronectin substratum.Additionally, the cells expressing themutant
PTP1B displayed an elongated morphology, with focal adhesions that were
reduced in size and number. A third study examined the behavior of fibroblasts
derived from PTP1B null mice (52). In this work, the cells lacking PTP1B
exhibited delayed spreading on a fibronectin-coated surface, but surprisingly
little effect was found in terms of tyrosine phosphorylation in response to
adhesion to fibronectin. However, when wild-type and PTP1B null cells were
transformed with SV40Tag, effects on tyrosine phosphorylation were seen.
Now the transformed null cells exhibited decreased tyrosine phosphorylation
of p130cas relative to transformed wild-type cells following short periods (20
min) of adhesion to fibronectin. These null cells also showed hyperphospho-
rylation of the inhibitory site in Src (Tyr527) in some situations. Notably, the
SV40Tag-transformed fibroblasts revealed an increased expression of PTP1B
relative to primary mouse embryo fibroblasts, possibly accounting for the dif-
ferences between the transformed and primary cells.
Can these apparently conflicting observationswith PTP1Bbe reconciled?As
the authors have suggested, cell type differences may be critical, especially
given that SV40Tag-transformed cells elevate expression of PTP1B (52). Cell
types may also diverge both as to where PTP1B is acting in adhesion signaling
pathways and in the degree of compensation by other PTPs. For example, in
some cell types PTP1B may have a major role regulating the COOH-terminal
inhibitory phosphorylation site of SFKs, whereas in other cell types different
PTPs (e.g. PTP or Shp-2)may bemore important. p130cas is amajor substrate
for Src; so in cells in which PTP1B is regulating Src activity, one would predict
lower phosphorylation of p130cas when PTP1B is absent or inactive (51, 52).
However, in other cell types where different PTPs may be more critical in
regulating SFK activity, the effect of depressing PTP1B activity would be pre-
dicted to be less significant in terms of p130cas phosphorylation. Since PTP1B
can also dephosphorylate p130cas, it would not be surprising in these cells to
observe that overexpression of wild-type PTP1B decreases the phosphoryla-
tion of this target protein (49). One of the striking observations from
Chernoff’s group is that the cells overexpressing PTP1B revealed enhanced
focal adhesions and stress fibers (49). This is suggestive of increased RhoA
activity and could arise because of dephosphorylation and inactivation of a
regulatory protein such as p190RhoGAP. However, this phenotype could also
result from defective focal adhesion disassembly (see below).
Focal Adhesion Disassembly: Downstream Regulation by PTPs
With the discovery of FAK activation in response to integrin-mediated
adhesion, it was widely interpreted that tyrosine phosphorylation promoted
focal adhesion assembly. However, the phenotype of FAK knock-out cells, as
well as cells in which FAK was displaced from focal adhesions, revealed robust
and stable focal adhesions in the absence of FAK and tyrosine phosphorylation
detectable by immunofluorescence (53, 54). Rather than assembly of focal
adhesions, FAK activity correlated with focal adhesion turnover and disassem-
bly (5). While several pathways downstream of FAK could contribute to focal
adhesion disassembly (5, 19, 55–59), a novel, endocytic pathway (60) suggests
a potentially important role for an as yet unidentified PTP. In this work, tyro-
sine-phosphorylated FAK was found to recruit dynamin to focal adhesions
(60). Dynamin is a protein involved in endocytosis and expression of a domi-
nant negative form of dynamin that inhibits endocytosis blocked focal adhe-
sion disassembly. The association of FAK with dynamin is mediated by the
adaptor proteinGrb2, which binds to phosphorylated Tyr925 in FAK and to the
proline-rich region of dynamin. Expression of the non-phosphorylatable FAK
mutant, Y925F, failed to rescue focal adhesion disassembly in FAK null fibro-
blasts (60).
Identification of the PTP that removes the phosphate from Tyr925 in FAK
will be important. Based on the above information, it would be predicted that
this PTPwould have a key role in regulating focal adhesion disassembly and, by
extension, in regulating cell migration. For cells to migrate, focal adhesions
must be disassembled so that strong adhesions to the underlying ECM can be
released. The PTP thatmediates dephosphorylation of Tyr925 in FAKwould be
anticipated to increase focal adhesion stability and decrease migration when it
is overexpressed but to increase migration rates and the turnover of focal
adhesions when it is inhibited or knocked out. This phenotype matches that
described by Liu and co-workers (49) when they overexpressed PTP1B in
fibroblasts, and it will be interesting to learn whether PTP1B or another PTP
regulates the phosphorylation status of Tyr925 in FAK.
Concluding Remarks
PTPs play critical roles in cell-matrix adhesion dynamics, an important
component of cell migration. An exciting area is the potential involvement of
PTPs in the initiation of signals following integrin engagement. It will be inter-
esting to determine whether different integrins associate with specific PTPs
and whether by activating different members of the Src family these trigger
distinct signaling cascades. Downstream of adhesions to the ECM, several
proteins become tyrosine-phosphorylated; many of these proteins are phos-
phorylated on multiple residues. Different PTPs are able to target specific
residues on phosphorylated proteins, and elucidating which sites are the tar-
gets for particular PTPs will contribute to understanding how different PTPs
can influence the outcome of signaling pathways. Whereas most attention has
been directed toward the role of PTPs in regulating tyrosine phosphorylation
downstream of integrins, PTPs are also important upstream, regulating the
assembly and disassembly of ECM adhesions. For instance, the action of PTPs
on Rho family GEFs and GAPs is only beginning to be investigated but prom-
ises to be crucial to understanding the dynamics of cell-matrix adhesion.
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Turner, C. E. (2005) J. Cell Sci. 118, 5835–5847
MINIREVIEW: Phosphatases in Cell-Matrix Adhesion
15596 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 281 • NUMBER 23 • JUNE 9, 2006
